Explore
Validate
Learn
Western blot
ImmunohistochemistryAntibody data
- Antibody Data
- Antigen structure
- References [3]
- Comments [0]
- Validations
- Immunohistochemistry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- HPA008428 - Provider product page
- Provider
- Atlas Antibodies
- Proper citation
- Atlas Antibodies Cat#HPA008428, RRID:AB_1079680
- Product name
- Anti-PGR
- Antibody type
- Polyclonal
- Description
- Polyclonal Antibody against Human PGR, Gene description: progesterone receptor, Alternative Gene Names: NR3C3, PR, Validated applications: IHC, WB, Uniprot ID: P06401, Storage: Store at +4°C for short term storage. Long time storage is recommended at -20°C.
- Reactivity
- Human
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 100 µl
- Concentration
- 0.1 mg/ml
- Storage
- Store at +4°C for short term storage. Long time storage is recommended at -20°C.
- Handling
- The antibody solution should be gently mixed before use.
Submitted references Cellular heterogeneity of human fallopian tubes in normal and hydrosalpinx disease states identified using scRNA-seq
Progesterone receptor negativity is an independent risk factor for relapse in patients with early stage endometrioid endometrial adenocarcinoma
Progesterone receptor negativity is an independent risk factor for relapse in patients with early stage endometrioid endometrial adenocarcinoma
Ulrich N, Shen Y, Ma Q, Yang K, Hannum D, Jones A, Machlin J, Randolph J, Smith Y, Schon S, Shikanov A, Marsh E, Lieberman R, Gurczynski S, Moore B, Li J, Hammoud S
Developmental Cell 2022;57(7):914-929.e7
Developmental Cell 2022;57(7):914-929.e7
Progesterone receptor negativity is an independent risk factor for relapse in patients with early stage endometrioid endometrial adenocarcinoma
Huvila J, Talve L, Carpén O, Edqvist P, Pontén F, Grénman S, Auranen A
Gynecologic Oncology 2013;130(3):463-469
Gynecologic Oncology 2013;130(3):463-469
Progesterone receptor negativity is an independent risk factor for relapse in patients with early stage endometrioid endometrial adenocarcinoma
Huvila J, Talve L, Carpén O, Edqvist P, Pontén F, Grénman S, Auranen A
Gynecologic Oncology 2013 September;130(3):463-469
Gynecologic Oncology 2013 September;130(3):463-469
No comments: Submit comment
Supportive validation
- Submitted by
- Atlas Antibodies (provider)
- Enhanced method
- Orthogonal validation
- Main image
- Experimental details
- Immunohistochemistry analysis in human endometrium and tonsil tissues using HPA008428 antibody. Corresponding PGR RNA-seq data are presented for the same tissues.
- Sample type
- Human
- Protocol
- Protocol
